Drug
Nateglinide clinical trials
- studies test it
- 13
- open now
- 0
- in phase 3
- 2
- first study started
- 2002
How studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
12 studies that test it; most in 2009 (3)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2009 | 3 |
| 2011 | 1 |
| 2012 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 1
- Phase 3
- 2
- Phase 4
- 8
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 4
Novartis Pharmaceuticals (4) · Astellas Pharma Inc (2) · Dr. Reddy's Laboratories Limited (2) · Atheline Major-Pedersen (1) · Ajou University School of Medicine (1) · IlDong Pharmaceutical Co Ltd (1) · Inje University (1) · University of Oslo School of Pharmacy (1)
Often tested with
Tested in the same studies.
Ipragliflozin (1) · Glimepiride (1) · Metformin (1) · Acarbose (1)
Studies
Open first, then newest update. How each study uses Nateglinide is read from its arms, and is right about nine times in ten.
Testing it · 13
- A Study to Assess Safety and Efficacy of ASP1941 in Combination With Nateglinide in Type 2 Diabetic PatientsCompletedPhase 3Astellas Pharma IncNCT01316107Written as nateglinide
- Insulin Resistance and Vessel Function After Meals: Does Early Intervention Make a Difference?CompletedPhase 4Atheline Major-PedersenNCT00259168Written as Nateglinide
- Study of the Durability of Glycemic Control With NateglinideCompletedPhase 4Ajou University School of MedicineNCT00858013Written as Nateglinide
- Safety and Efficacy of Nateglinide in Patients With Type 2 Diabetes Already Taking Insulin Glargine, Metformin and/or Pioglitazone or RosiglitazoneCompletedPhase 4Novartis PharmaceuticalsNCT00402909Written as Nateglinide
- A Open-label, Single-dose, 2-Sequence, 2-Period, Crossover Study to Assess Safety and Pharmacokinetics of a Nateglinide/Metformin HCl Combined Tablet Compared With a Nateglinide 120 mg Tablet and Metformin HCl 500 mg Tablet Under Fasting Conditions in Healthy Male SubjectsCompletedPhase 1IlDong Pharmaceutical Co LtdNCT02088918Written as Nateglinide
- Effects of Nateglinide on Postprandial Glucose Excursion by Restoring Early Phase Insulin SecretionCompletedPhase 4Novartis PharmaceuticalsNCT01030952Written as Nateglinide
- Effects of Nateglinide vs Acarbose on Postprandial Glucose Fluctuation, Dyslipidemia, and Inflammatory FactorsCompletedPhase 4Novartis PharmaceuticalsNCT00928889Written as Nateglinide 120 mg
- A Pilot Study to Evaluate the Effects of Nateglinide vs. Glibenclamide on Renal Hemodynamics and Albumin ExcretionCompletedPhase 4Novartis PharmaceuticalsNCT00238472Written as nateglinide
- Bioequivalence Study of Nateglinide Tablets 120 mg of Dr. Reddy's Laboratories Limited Under Fed ConditionCompletedPhase 1Dr. Reddy's Laboratories LimitedNCT01160029Written as Nateglinide
- Bioequivalence Study of Nateglinide Tablets 120 mg of Dr. Reddy's Laboratories Limited Under Fasting ConditionCompletedPhase 1Dr. Reddy's Laboratories LimitedNCT01159158Written as Nateglinide
- The Effects of Nateglinide and Acarbose on the Post-Prandial Glucose Control in Type 2 Diabetic PatientsCompletedPhase 4Inje UniversityNCT00437918Written as nateglinide
- Nateglinide: a Double Blind Add-on Study With Pioglitazone for Type 2 Diabetic PatientsCompletedPhase 2/3Astellas Pharma IncNCT00189774Written as nateglinide
- Efficacy and Safety of Nateglinide Treatment in Renal Transplant RecipientsCompletedPhase 4University of Oslo School of PharmacyNCT00319189Written as Nateglinide
Codes
What other systems call Nateglinide · ClinicalTrials.gg INT006788
- MeSH (NLM) D000077715NateglinideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 41X3PWK4O2NATEGLINIDEConfirmed FDA, NLM, Wikidata
- RxNorm 274332Confirmed FDA, Wikidata
- Wikidata Q2254797nateglinideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61858NateglinideOne source FDA
- DrugBank DB00731One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077715 | Nateglinide | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 41X3PWK4O2 | NATEGLINIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 274332 | — | Confirmed FDA, Wikidata |
| Wikidata | Q2254797 | nateglinide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61858 | Nateglinide | One source FDA |
| DrugBank | DB00731 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.